These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18434040)

  • 21. [Clinical applications of transcranial magnetic stimulation for the treatment of various neurological diseases].
    Tsuji S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):831-3. PubMed ID: 16447738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.
    Rachid F; Golaz J; Bondolfi G; Bertschy G
    World J Biol Psychiatry; 2006; 7(4):261-4. PubMed ID: 17071547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible involvement of brain-derived neurotrophic factor in the antinociceptive effect of antidepressants in neuropathic pain.
    Tsai SJ
    Med Hypotheses; 2005; 65(3):530-3. PubMed ID: 15905042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.
    Cohen RB; Boggio PS; Fregni F
    Depress Anxiety; 2009; 26(7):682-8. PubMed ID: 19170101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods of therapeutic cortical stimulation.
    Lefaucheur JP
    Neurophysiol Clin; 2009 Feb; 39(1):1-14. PubMed ID: 19268842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive brain stimulation for the management of arterial hypertension.
    Cogiamanian F; Brunoni AR; Boggio PS; Fregni F; Ciocca M; Priori A
    Med Hypotheses; 2010 Feb; 74(2):332-6. PubMed ID: 19775822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic applications of repetitive transcranial magnetic stimulation in clinical neurorehabilitation.
    Machado S; Bittencourt J; Minc D; Portella CE; Velasques B; Cunha M; Budde H; Basile LF; Chadi G; Cagy M; Piedade R; Riberio P
    Funct Neurol; 2008; 23(3):113-22. PubMed ID: 19152730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial direct current stimulation: a new tool for the treatment of depression?
    Arul-Anandam AP; Loo C
    J Affect Disord; 2009 Oct; 117(3):137-45. PubMed ID: 19201483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General principles for clinical use of repetitive transcranial magnetic stimulation (rTMS).
    Maertens de Noordhout A
    Neurophysiol Clin; 2006; 36(3):97-103. PubMed ID: 17046604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neurophysiological insight into the potential link between transcranial magnetic stimulation, thalamocortical dysrhythmia and neuropsychiatric disorders.
    Fuggetta G; Noh NA
    Exp Neurol; 2013 Jul; 245():87-95. PubMed ID: 23063603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: a review of the literature.
    Bae EH; Schrader LM; Machii K; Alonso-Alonso M; Riviello JJ; Pascual-Leone A; Rotenberg A
    Epilepsy Behav; 2007 Jun; 10(4):521-8. PubMed ID: 17493877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series.
    Milev R; Abraham G; Hasey G; Cabaj JL
    J ECT; 2009 Mar; 25(1):44-9. PubMed ID: 18665102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic therapies for treatment-resistant depression: new neurotherapeutic interventions.
    Dougherty DD; Rauch SL
    Psychiatr Clin North Am; 2007 Mar; 30(1):31-7. PubMed ID: 17362801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What is needed for rTMS to become a treatment?].
    Foucher JR; Luck D; Chassagnon S; Offerlin-Meyer I; Pham BT
    Encephale; 2007 Dec; 33(6):982-9. PubMed ID: 18789791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To BDNF or not to BDNF: that is the epileptic hippocampus.
    Koyama R; Ikegaya Y
    Neuroscientist; 2005 Aug; 11(4):282-7. PubMed ID: 16061515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasticity in the developing brain: implications for rehabilitation.
    Johnston MV
    Dev Disabil Res Rev; 2009; 15(2):94-101. PubMed ID: 19489084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.
    Kuipers SD; Bramham CR
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):580-6. PubMed ID: 17002218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it time to reassess the BDNF hypothesis of depression?
    Groves JO
    Mol Psychiatry; 2007 Dec; 12(12):1079-88. PubMed ID: 17700574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.